Turmeric
Comparative Absorption of a Standardized Curcuminoid Mixture and Its Lecithin Formulation
Thus, the major plasma curcuminoid after administration of Meriva was not curcumin (1a), but demethoxycurcumin (1b), a more potent analogue in many in vitro anti-inflammatory assays. The improved absorption, and possibly also a better plasma curcuminoid profile, might underlie the clinical efficacy of Meriva at doses significantly lower than unformulated curcuminoid mixtures.Download the research paper
Efficacy and Safety of Meriva®, a Curcumin-phosphatidylcholine Complex, during Extended Administration in Osteoarthritis Patients
In a previous three-month study of Meriva®, a proprietary curcumin-phosphatidylcholine phytosome complex, decreased joint pain and improvement in joint function were observed in 50 osteoarthritis (OA) patients. Since OA is a chronic condition requiring prolonged treatment, the long-term efficacy and safety of Meriva were investigated in a longer (eight months) study involving 100 OA patients.
Download the research paper
Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial
Curcumin has the potential for preventing DOMS, as suggested by its effects on pain intensity and muscle injury.
Download the research paper
The concept of Meriva® based on the biometric principle Nature As Measure™
Chronic inflammation is the silent killer of our health. According to the World Health Organization, more than a third of the 57 million deaths each year in the world are provoked by chronic diseases that are the main cause of death [cardiovascular diseases, type-2 diabetes, hypertension, respiratory diseases and Alzheimer’s]. 90% of these diseases have an inflammatory origin.
Download the research paper
Further Questions?
Your health is very important, so it is natural to have questions. If we haven’t answered all of yours, please check our Research section or get in touch - Sam Hunter 0403388771 Contact Us
Contact us at K9health
'BOUT TIME (FOR SOLUTIONS) Pty Ltd
PO Box 607
Balgowlah NSW 2093
T: +61 (0) 403 388 771
E: sam@bouttime.com.au